Adults with type 2 diabetes who have not achieved adequate blood sugar control despite multiple treatments may qualify for a research study evaluating an investigational oral medication targeting cortisol-related metabolic dysfunction.
Type 2 Diabetes
Age Range:
18
Gender:
Male and Female
Location:
West Chester, Pennsylvania
About the Study
This research study is evaluating an investigational medication called clofutriben, which works by inhibiting an enzyme involved in cortisol regulation. By reducing the effects of excess cortisol, this therapy may help improve blood sugar control and overall metabolic health.
The purpose of this study is to better understand how well this medication works compared to placebo (inactive treatment), and to evaluate its safety in people with type 2 diabetes and elevated cortisol levels.
Qualifications
You may be able to join if you:
- Are 18 years of age or older
- Have type 2 diabetes for at least 1 year
- Have an HbA1c (blood sugar level) of 7.5% or higher
- Are currently taking at least two diabetes medications at stable doses
- Have difficulty achieving blood sugar control despite treatment
If you’re interested in participating or want to learn more, contact us today to see if you may qualify.
FEATURED STUDIES
MDD Study
Adults 18 to 65 years of age with Major Depressive Disorder (MDD) may qualify for a clinical research study evaluating
Asthma
Adults and adolescents 12 years of age and older living with asthma may qualify for a clinical research study evaluating
Chronic Obstructive Pulmonary Disease (COPD)
Adults 40–75 who have COPD and experienced a flare-up in the past year may qualify for a study evaluating an
Post-Traumatic Stress Disorder (PTSD)
Adults 18 and older living with post-traumatic stress disorder (PTSD) may qualify for a clinical research study evaluating an investigational
Bronchiectasis
Individuals with bronchiectasis who experience frequent flare-ups or ongoing respiratory symptoms may qualify for a research study evaluating a home
Hypertension & Type 2 Diabetes
Researchers are studying an investigational medication to see how effective it may be in reducing risk of heart failure for